Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipsychotic Monotherapy vs Combination with Divalproex in Dementia Agitation
NCT00208819Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of divalproex sodium in agitation and Dementia (2 arms), sponsored by Emory University. Primary endpoints: Pittsburgh Agitation Scale, DiMarco Rating Scale for Extrapyramidal Symptoms and 6 more. Started Sep 2003; status: completed.
02
Drugs
divalproex sodium
03
Conditions
agitationDementia
Beyond the preview
Go deeper on NCT00208819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208819.